SMILES string
CCCC[C@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(O)=O
assay
>98%
UniProt accession no.
storage temp.
−20°C
Gene Information
human ... TAC1(6863)
Biochem/physiol Actions
Potent NK-2 tachykinin receptor agonist.
法规信息
新产品
此项目有
L Fisher et al.
Regulatory peptides, 46(1-2), 396-398 (1993-07-02)
Tachykinin receptors mediating uterotonic effects were examined in preparations from oestrogen-primed rats. In the absence of peptidase inhibitors [Lys5-MeLeu9-Nle10] NKA (4-10) was 14-fold more potent than neurokinin A (NKA), but the two peptides were equipotent in the presence of phosphoramidon
J L Black et al.
British journal of pharmacology, 107(2), 429-436 (1992-10-01)
1. In many species, both NK1 and NK2 tachykinin receptors appear to be important in mediating the contraction of airway smooth muscle. We have examined the distribution and characterization of receptors for tachykinins in rabbit airways using functional length tension
G Chassaing et al.
Neuropeptides, 19(2), 91-95 (1991-06-01)
All the synthetized NKA and NKA (4-10) agonists have been found active in the rat portal vein bioassay. Even [Lys5, MeLeu9, Nle10] NKA(4-10), a highly potent competitor of NK-2 binding sites with very low binding potencies for NK-1 and NK-3
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持